Sanofi-Aventis Animal Health

Go back to homepage


Sanofi-Aventis Animal Health
Financial Details
Total Company Revenue in 2010 $ 30.384 Bn
Revenue from Animal Health Market in 2010 $ 2.635 Bn
% of revenue from Animal Health in 2010 8.67%
Segmentwise Revenue Breakup ($ Bn)
Livestock Vaccines 1.021
Companion Vaccines 1.614
Number of Major Vaccines (Animal-wise)
Poultry 0
Swine 0
Fish 0
Sheep 0
Cattle 0
Canine 3
Feline 2
Equine 2
Mergers and Acquisitions (2009 - 2011) Consideration
Merial Ltd $ 4 Bn
Future Focus Areas
Veterinary Vaccines under trial 0
Future Focus Areas of the company in the Veterinary Vaccines Market Viral and parasitological vaccines
In pharmaceutical R&D, we have 120 ongoing projects focusing on parasiticides, anti-infectives and internal medicine (endocrine/pain) and performance products. Meanwhile in biological R&D, we have 140 projects in progress focusing on zoonotic and emerging diseases, respiratory diseases, enteric diseases and enabling technologies.



Go back to homepage